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Is peritoneal dialysis adequate for hypercatabolic acute renal Acute renal failure (ARF) remains a common and po-
failure in developing countries? tentially devastating disorder affecting as many as 5 to
Background. Peritoneal dialysis (PD) is a therapeutic option 8% of all hospitalized patients, with a higher prevalencefor acute renal failure (ARF) in developing countries, despite
in patients in critical care units [1]. ARF in the developedconcerns about inadequacy. Shorter and more efficient tidal
world is more frequently observed in association withperitoneal dialysis (TPD) was compared with continuous equil-
ibrating peritoneal dialysis (CEPD) therapy in ARF by using multi-organ dysfunction and in elderly patients with com-
their adequacies as accepted standards and analyzing the solute plex diseases and surgical trauma (56.9%), where the mor-
reduction indices (SRI). tality remains high [1]. In developing countries, ARF is
Methods. A prospective, randomized crossover trial was
more common secondary to medical causes, namely, isch-performed in patients with mild to moderate hypercatabolic
emic acute tubular necrosis from renal hypoperfusion,ARF who were assigned to CEPD and TPD therapy after an
adequate washout period. Solute clearances (Kt/V, normal- infections, insect bites, and pregnancy related causes [2].
ized creatinine clearances) were compared to NKF guidelines. Patients with ARF and the dialysis centers that treat
Potassium and phosphate clearances, dextrose absorption, pro- them face unique problems in developing countries, such
tein losses and costs were compared. Kt/V was compared to
as India. First, dialysis is available only at a few centersSRIdialysate, SRIKt/V.
in certain metropolitan cities and many of these centersResults. Eighty-seven patients with ARF received 236 ses-
are not equipped to provide all modalities of renal re-sions of dialysis (118 in each treatment). TPD resulted in higher
clearances of solutes than CEPD (creatinine and urea clear- placement therapy on an emergency basis. In addition,
ances in mL/min of 9.94  2.93, 6.74  1.63 and 19.85  the limited availability of hemodialysis beds, technical
1.95, 10.63  2.62, respectively, P  0.001). TPD and CEPD and trained nursing staff, and sharing of hemodialysisnormalized creatinine clearances (L/week/1.73 m2 BSA) and
beds by chronic renal failure (CRF) patients influenceKt/V values were 68.5  4.43, 58.85  2.57 and 2.43  0.87,
the choice of therapy for the patients with ARF. For1.80  0.32, respectively. CEPD did not meet standards of
adequacy. TPD resulted in greater potassium and phosphate example, our center at the King Edward Memorial Hos-
clearances, less dextrose absorption and was less expensive. pital at the University of Bombay, one of the largest
CEPD resulted in less protein loss. Kt/V corresponded to tertiary care multi-specialty hospitals in India, annually
SRIdialysate 0.88  0.12 (P  0.076). treats an average of 1000 to 1100 in-patients in a nephrol-Conclusion. TPD produced higher solute clearances in less
ogy service consisting of just 34 beds and 20 hemodialysistime with greater protein loss. CEPD just fell short to meet
the dialysis adequacy standard. However, both TPD and CEPD machines. Second, dialysis centers experience periodic
are reasonable options for mild-moderate hypercatabolic ARF. increase in demands according to seasonal variations in
Kt/V appropriately estimates solute removal in PD. the incidence of ARF. We experience an 18 to 23%
increase in admission during the monsoon season (rain-
fall, between July and September) due to increase in
Key words: continuous equilibration peritoneal dialysis, tidal perito-
acute gastro-enteritis and other communicable diseases,neal dialysis, Kt/V, creatinine clearance, solute reduction index, ade-
quacy of dialysis, end-stage renal disease, India and dialysis. like malaria and leptospirosis. Third, the cost of treat-
ment is an extremely crucial factor in the selection of
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lent to US $120) and that of PD equipment is Rs. 250 catabolic ARF patients, and to evaluate the adequacy
of both types of PD in terms of Kt/V, normalized creat-to 300 (equivalent of US $5 to 7). To put that into per-
spective, the cost of hemodialysis equipment is more inine clearance and modified solute reduction indices
(SRIdialysate and SRIKt/V) [16]. The main objective was tothan one quarter of the average monthly income of an
Indian family (per capita GNP  US $390) [3]. Most of examine the adequacies of both the modalities in ARF
rather than to compare high flow dialysis (TPD) withthe patients are referred approximately one to three
days after the onset of ARF. An additional delay of low flow dialysis (CEPD), where the former is expected
to yield higher solute clearances. In the absence of ac-approximately 6 to 12 hours occurs when transferring
patients from the medical floors to the dialysis unit due cepted standards of adequacy in ARF, clearances were
compared to standards derived for CRF patients as pro-to long waiting lists. Five to eight percent of patients
have to be referred to other dialysis centers for lack of posed by the National Kidney Foundation (NKF), and
used in other studies of ARF with HD [16, 18]. SRI isbeds.
Peritoneal dialysis (PD) for ARF still constitutes the a dialysate-based kinetic method, considered the gold
standard in HD, but it has not been studied in PD [19].mainstay of therapy in the tropics due to its availability
and ease of administration [4]. PD offers several advan- We wanted to compare a modified SRI with Kt/V to
determine the amount of solute removal in PD. A costtages over HD, such as technical simplicity, absence of
an extracorporeal circuit, no bleeding risk, excellent car- comparison analysis was performed for these two types
of PD.diovascular tolerance and low risk of hydro-electrolyte
disequilibrium. PD also has some limitations, such as risk
of peritoneal infection, occurrence of obligatory protein
METHODS
loss, need for an intact peritoneal cavity and overall
Study populationlower effectiveness. Traditionally, at our center, continu-
ous equilibration peritoneal dialysis (CEPD) is offered This was a prospective, randomized crossover study,
performed with the approval of the hospital ethics com-to patients with ARF with cardiovascular instability, co-
agulopathies and without evidence of severe hypercata- mittee of King Edward Memorial Hospital, University of
Bombay, India. Informed written consent was obtainedbolic state for 24 to 48 hours. An overwhelming demand
for dialysis beds and hemodialysis machines prompted us from all study participants. This tertiary referral center
in the city of Greater Bombay (Mumbai) is an 1800 bedto evaluate a more efficient type of PD, tidal peritoneal
dialysis (TPD), to facilitate more effective use of scarce hospital, which treats 1.6 to 1.7 million outpatients and
62 to 64,000 inpatients annually; it has a catchment areamedical resources and help make the turnover of beds
for dialysis more efficient. TPD used in CRF patients of approximately 10 million people from the city of Bom-
bay and surrounding areas of western India.has been shown to increase solute clearances by 13 to
25% over nocturnal intermittent peritoneal dialysis using Consecutive patients with hypercatabolic ARF who
were referred to the dialysis service during the six-monththe same volume of fluid [5].
Because the daily clearances of solutes are lower with study period, between 12 to 80 years of age and hemody-
namically stable, were considered for the study. Hyperca-PD than with daily hemodialysis, there has been concern
that PD cannot control the uremia seen in acutely ill tabolic renal failure was defined as acute renal shut down
with an increase of BUN 30 mg/dL/day and creatinineARF patients [6]. Most of the studies that have evaluated
PD in hypercatabolic ARF reported PD as having ade- 1 mg/dL/day with one of the following: an increase in
serum potassium 1 mEq/L/day, serum uric acid 15quate and satisfactory control of fluid and metabolic
derangements [7–14]. However, small sample sizes, inad- mg/dL, serum phosphate8 to 10 mg/dL and a decrease
of serum bicarbonate 2 mEq/L/day [20]. Patients wereequate measurement of catabolic status, and lack of ap-
propriate measurements of dialysis adequacy were major grouped into mild, moderate and severe hypercatabolic
ARF according to the severity of catabolism as estimatedlimitations of these studies [7–14]. Arbitrarily defined
optimum levels of post-dialysis blood urea nitrogen by the excess urea appearance rate (UNA) (vide infra)
[21]. Patients with mild-moderate hypercatabolic ARF(BUN) and creatinine were used as crude indices of
dialysis adequacy. Furthermore, it has been increasingly (excess UNA, above the dietary nitrogen intake up to
12 g/day) were randomized in the trial. Patients with anyrecognized that the delivered dose of dialysis influences
patient outcomes in ARF and that the dose delivered to of the following conditions were excluded: hemodynamic
instability (systolic blood pressure80 mm Hg), pulmo-patients with ARF by hemodialysis (HD) is inadequate
[15–17]. Given these limitations, there is a pressing need nary edema, severe metabolic acidosis (blood pH 7.2
and plasma bicarbonate 14 mEq/L), and excess UNAto re-evaluate the adequacy of PD in ARF using ac-
cepted standards. of more than 12 g/day (severe hypercatabolic renal fail-
ure) [21]. Traumatic PD and malfunctioning dialysis ses-The present prospective study was designed to explore
the role of TPD and CEPD in mild-moderate hyper- sions were excluded from the final analysis.
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Table 1. Dialysis protocols for tidal peritoneal dialysis (TPD) and for registered nurses, nursing supervisors, technicians,
continuous equilibrating peritoneal dialysis (CEPD)
clerical and housekeeping services, and resident doctors;
Treatment CEPD TPD consumables, including needles, syringes, intravenous
Initial fill volume (mL) for solutions, intravenous sets, office supplies, minor equip-
artificial ascites 2000 2000 ment, vacutainers, and other purchases; dietary supplies;
Dialysate fluid/cycle mL 2000 675 (tidal volume)
standing expenses like maintenance engineering, power,Inflow time min 10 5
Dwell time min 210 10 telecommunications, data processing, hospital security,
Outflow time min 20 5 administrative and quality control expenses). Taxes, de-
Tidal drain mL — 750
preciation of various items and bed debts were includedReserve volume mL — 1325
Duration/cycle min 240 20 in calculating the cost of a dialysis bed [23]. Cost of
Total exchanges/session 12 36 dialysis consumables was also calculated from the cost
Total duration of session hours 48 12
of a dialysis set, Baxter dialysate fluid and the CyclerTotal volume (L) of dialysate
per session 26 26.3 PAC-Xtra 2 machine, as well as the expense of machine
Flow rate mL/min 9 36.5 maintenance. The cost of the machine/person was calcu-
lated by dividing the total cost (inclusive of cost of hard-
ware, shipping and handling) by the number of patients
likely to use the machine during its lifespan (on average
Anthropometric measurements [height, weight and 20 patients use the machine a month for a minimum of
body surface area (BSA) calculated from DuBois for- 8 to 10 years). Cost was calculated in Indian rupees (Rs.;
mula] [22] were obtained before initiating dialysis. Prior US $1  45 Indian Rupees). To make international
to initiation of dialysis, a skilled renal dietician super- cost comparison more meaningful, costs in international
vised dietary intake and a 24-hour urine was collected dollars (I $) also were calculated. The calculation is ob-
for urea and creatinine estimation. tained by adjusting for the purchasing power parity fac-
tor, which is defined as the number of units of a country’s
Treatment protocols
currency required to buy the same amount of goods or
Patients were randomly allocated as per a standard services in the domestic market as the US $1 would
random number table to either treatment A or B, where buy in the United States [24]. The international dollar
treatment A was TPD and B was CEPD. The patients represents differences in purchasing power not covered
were crossed over to the other treatment protocol after by the official exchange rates. Therefore, Rs. 10.94 spent
a minimum washout period of 12 hours. The patients in India are equal to I $1 (or US $ spent in the United
were randomized again if the need for dialysis persisted States).
after the initial session. Those patients who completed
Analysis of samplesat least one set of dialysis (CEPD  TPD or TPD 
CEPD) were included in the final analysis. Blood samples were collected at baseline for the calcu-
Peritoneal access was established by a stylet catheter lation of catabolism; samples also were collected at base-
(stiff non-cuffed inert catheter equivalent to a Cook line and the end of dialysis for the measurement of urea
catheter) introduced in the midline, infra-umbilically by nitrogen, creatinine, total protein, sodium, potassium,
standard procedure after creating artificial ascites with calcium, phosphate and glucose. The samples were ana-
2 L of peritoneal dialysis fluid (Dianeal 2.5%; Baxter lyzed using a Hitachi 717 analyser (Boehinger-Mann-
Healthcare Corporation, Deerfield, IL, USA). An infu- heim, Rotkreuz, Germany). The dialysate effluent was
sion volume of 2 L was selected, as our patient population collected in two large drainage bags (capacity of 15 L/ bag)
would not tolerate higher intra-peritoneal volume sec- and the bags were stored at 20C. An aliquot of 200
ondary to their small average body size. A peritoneal mL of dialysate was removed after thorough mixing of
dialysis solution (Dianeal 2.5%) without heparin or the storage bag and was analyzed for the biochemical
potassium was used for both the protocols (Table 1). parameters described below.
TPD and CEPD were performed by PAC-Xtra 2 (Bax- Dialysate urea nitrogen was measured by the Diacetyl
ter Healthcare Corporation) and manually, respectively. monoxime method, and creatinine estimations were per-
Clinical assessment was performed at six-hour intervals. formed using the modified Jaffe reaction. The coeffi-
Patient satisfaction (assessed by pain and comfort during cients of variation (CV) of dialysate urea nitrogen and
dialysis) was evaluated on a semiquantitative scale, creatinine assays were 2.3% to 3.5%, respectively. Mea-
where 0  no satisfaction and 3  highest level of satis- surement of dialysate total protein was performed by
faction. turbidimetric analysis using trichloroacetic acid with
A cost comparison analysis was performed between Ponceau-S dye and that of albumin by the timed end-
the two types of PD by including dialysis bed charges point method with Bromocresol Blue. The CV for pro-
tein estimation was from 3.2% to 4.0%. Dialysate glucose(calculated by factoring per unit hour of labor charges
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was analyzed by the glucose oxidase-peroxidase meth- dialysis (min) and V  volume of distribution of urea
as calculated by the Watson formula [28].od and electrolytes by ISE (ion specific electrode).
Modified solute reduction indices. The modified soluteSince glucose interferes with the Jaffe reagent for crea-
reduction indices were calculated as follows [16].tinine estimation, dialysate creatinine was corrected by
0.000531415 for each mg/dL of dialysate glucose [25].
SRIDialysate 
Total urea in dialysate (g)  100%
(Pre-dialysis BUN g/L)  TBW (L)
Dialysate phosphate was estimated by the timed end-
point method with ammonium molybdate. Dialysate was
SRIKt/V  1 eKt/V  100 (Eq. 3), (Eq. 4)cultured for aerobic and anaerobic bacteria using appro-
priate culture media.
Statistical analysis
Calculations
The non-parametric variables, namely, serum urea ni-
Assessment of catabolism trogen, creatinine, potassium, glucose, protein, albumin
and phosphate were expressed as mean  SD. SinceNitrogen balance  dietary N  (UN output  NUN losses)
each patient served as his/her own control, pre- and post-(Eq. 1)
dialysis BUN and creatinine values were compared for
Dietary protein and calories were calculated from the the two treatment groups using the paired t test. Ade-
24-hour dietary intake of patients closely supervised by quacy of the washout period in-between two sessions of
a skilled renal dietician. Total protein intake was calcu- dialysis was evaluated by examining the effect of the
lated as per standard charts [26]. Dietary nitrogen (N) previous session on the subsequent session. This was
was calculated as 16% of the biological protein intake performed by the paired t test as follows: dialysate urea
[27]. None of the patients was on enteral or parenteral (DCurea) and creatinine (DCCr) clearances were comparedhyperalimentation and hence the sole nitrogen input was between T1 and T2, where T1 was the first (T → C
dietary protein intake. Since urea is the major nitroge- sequence) and T2 was the second session (C → T se-
nous waste product of protein and amino acid degra- quence). A similar analysis was performed for the CEPD
dation, urea nitrogen appearance (UNA) was used to group [(C1) with (C2)]. Kt/V and SRI between both
estimate nitrogen output [27]. UNA was calculated as treatment groups and within the same group (CEPD and
follows: UNA (g/day)  urine urea nitrogen (g/day)  TPD) were compared by the paired t test. Similarly,
Change in body urea nitrogen (g/day)  Dialysate urea SRIdialysate, SRIKt/V within the same treatment group were
nitrogen (g/day). Change in body urea nitrogen g/day  compared with the paired t test. The differences in potas-
(SUNf  SUNi, g/L/day)  (BWi  0.60)  (BWf  sium and phosphate clearances and protein and albumin
BWi, kg)  SUNf (g/L)  1.0 L/kg, where SUN is serum losses were compared by the paired t test. SAS version
urea nitrogen, BW is the patient’s actual body weight, 7.0 was used for the statistical analysis (SAS Institute
and i and f are the beginning and end of the study period, Inc., Chicago, IL, USA) [29].
respectively. Dialysate urea would be  0, as UNA esti-
mation was performed before beginning dialysis.
RESULTSNon-urea N (NUN), the nitrogen lost in sweat, respira-
tion, flatus, phlebotomy, and growth of skin, hair and A total of 113 patients with ARF were referred to the
nails, was computed as 0.031g N/kg/day [27]. Excess of Division of Nephrology for dialysis support over the six-
urea appearance was then calculated as the difference month period. Twenty patients with severe hypercata-
in the intake of N and UNA  NUN. Based on this bolic ARF (excess UNA above nitrogen intake12 g/day)
calculation patients were categorized as having mild (6 secondary to burns (N  5), septicemia (N  7), trau-
g/day), moderate (6 to 12 g/day) and severe (12 g/day) matic rhabdomyolysis (N  3), hemolytic uremic syn-
hypercatabolism, as proposed by Druml [21]. drome (HUS) and thrombotic thrombocytopenic pur-
Clearance of urea nitrogen and creatinine. Urea nitro- pura (TTP; N  5) were excluded from the study. Three
gen and creatinine were calculated as follows: patients were excluded due to traumatic and/or malfunc-
tioning dialysis, and three patients improved without
Clearance 
Dialysate volume  Concentration of solute
(P1  P2)/2
further need of dialysis after a single session of PD.
These 26 excluded patients received hemodialysis for(Eq. 2)
two to seven weeks. Three out of five patients with burns
where P1 is the serum solute concentration before dialysis and four out of seven patients with septicemia suc-
and P2 is the serum solute concentration at the end of cumbed due to the causes unrelated to hemodialysis.
dialysis. Creatinine clearance was normalized to 1.73 m2 Two patients with the TTP/HUS progressed to chronic
BSA, and urea clearance was expressed in both mL/min dialysis.
Baseline demographic and clinical characteristics ofand Kt/V, where K  clearance in mL/min, t  time on
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Table 2. Baseline demographic and clinical characteristics of cohort (N  87)
Characteristics Valuesa Characteristics Values
Urine output mL 32528 (50–1386) Serum sodium mEq/L 1328.7 (120–156)
Systolic blood pressure mm Hg 11020 (85–148) Serum potassium mEq/L 6.93.2 (4.7–7.1)
Diastolic blood pressure mm Hg 9616 (72–110) Total protein g/dL 4.81.76 (3.9–6.1)
Total protein intake g/day 30.211.7 (13.57–48.9) Serum albumin g/dL 3.11.8 (2.6–4.1)
Urea nitrogen appearance rate g/day 38.9711.38 (22.23–51.95) Serum calcium mg/dL 8.91.7 (7.1–10)
Excess of UNA g/day 7.423.65 (3.65–11.72) Serum phosphorous mg/dL 7.52.6 (5.1–10.6)
Pre-dialysis BUN mg/dL 78.1912.8 (60–145) Serum uric acid mg/dL 6.82.7 (3–12.8)
Pre-dialysis creatinine mg/dL 8.191.56 (5.8–10.3)
a Values are presented as mean  SD (range)
Table 3. Causes of acute renal failure (N  87)
Diagnosis N patients Contributory factors
Renal hypoperfusion and ischemic ATN 20 Acute gastroenteritis (19)
Complete heart block (1)
Leptospirosis 15 Jaundice, dehydration, DIC
Glucose-6: phosphate deficiency with hemolysis 12 Following ingestion of drugs like Primaquine, Quinidine and Dapsone
Liver diseases 2 Cirrhosis with hematemesis and shock leading to acute tubular necrosis
(ATN)
Snake bite 11 Elapidae (5) leading to disseminated intravascular coagulation (DIC)
Vipiridae (6) leading to cellulitis and S. aureus septicemia
Malaria 10 Malignant Falciparum malaria with DIC, dehydration
Drug-induced ATN 3 Rifampicin-induced interstitial nephritis (1)
Gentamicin-induced ATN with dehydration and contrast nephropathy (2)
Glomerular diseases 2 Rapidly progressive glomerulonephritis (1)
Acute nephritic syndrome (post-streptococcal glomerulonephritis) (1)
Acute pyelonephritis 2 Klebsiella pneumonia in solitary kidney
Surgical 8 Post-cardiac and aortic surgeries
Obstetrics 2 Toxemia of pregnancy with DIC
the 87 patients included in the analysis are shown in cantly lower than pre-dialysis levels in both the groups
(BUN lowered by 35.4% in TPD and 17% in CEPD,Table 2. The mean  SD of age was 34.7  10.6 years
and the male:female ratio was 1.6:1. The mean  SD of while creatinine lowered by 38% in TPD and 15% in
CEPD; Table 4). Post-dialysis BUN and creatinine val-weight and the BSA were 62.3  8.6 kg, 1.56  0.8 m2,
respectively. Medical causes of the ARF predominated ues were significantly lower in TPD compared to CEPD
(P values were 0.04 and 0.02, respectively). Clearances(88%), while surgical (9%) and obstetric causes (2%)
accounted for the remainder (Table 3). A total of 236 of urea and creatinine in mL/min were significantly dif-
ferent between TPD and CEPD (with TPD  CEPD).treatment sessions on 87 patients were analyzed
(CEPD  118 and TPD  118). Normalized creatinine clearance and Kt/V were signifi-
cantly higher in TPD, as were SRI (Table 4). The esti-Pre-dialysis BUN and creatinine values were not sig-
nificantly different between the two groups (Table 4). mated weekly Kt/V for CEPD of 1.80 and normalized
creatinine clearance of 58.85 L/week/1.73 m2 BSA fellThe mean  SD of the washout period was 15  2.5
hours (range 12.8 to 20.4 h). Pre-dialysis BUN values in short of matching the standards of adequacy as proposed
by the NKF (weekly Kt/V of	2.0 and normalized creati-the group where TPD was received first (T1) versus the
group receiving it second (T2) were 73  21.5 and 79  nine clearance of 	60 L/week/1.73 m2 BSA for CAPD)
[18]. The estimated weekly Kt/V and normalized creati-13.6 mg/dL, respectively (P  0.087, NS). Serum creati-
nine values in the T1 and T2 groups were 8.3  1.9 and nine clearance in TPD were 2.43 and 68.5 L/week/1.73
m2, respectively (Table 4). Hence, the TPD exceeded7.6  1.7 mg/dL, respectively (P  0.075, NS). Similar
observations were obtained for CEPD (pre-dialysis BUN the standards of adequacy as per the NKF guidelines
(weekly Kt/V of 	2.2 and normalized creatinine clear-in C1 of 74  15.3 mg/dL and C2 of 73  10.4 mg/dL,
and creatinine of 7.6  1.2 mg/dL in C1 and 7.4  1.6 ance 	66 L/week/1.73 m2 BSA for APD) [18].
Overall, Kt/V corresponded to SRI of 0.88 0.12 (Pmg/dL in C2; both P  NS). Thus, the washout period
was adequate, as the sequence of dialysis had no bearing 0.093). In the TPD group no significant differences were
noted in Kt/V, SRIdialysate or SRIKt/V; Kt/V correspondedon urea and creatinine clearances.
Post-dialysis BUN and creatinine levels were signifi- to 0.86  0.06 of SRIdialysate and 0.92  0.04 of SRIKt/V
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Table 4. Pre- and post-dialysis BUN and creatinine, solute clearances (Kt/V, normalized creatinine clearances and solute removal indices)
and ultrafiltrate in TPD and CEPD
TPD CEPD
Variables Mean  SD Range Mean  SD Range P value
Pre-dialysis BUN mg/dL 78.808.30 68–125 77.9622.10 63–118 0.67
Post-dialysis BUN mg/dL 50.8411.30 42–68 64.7112.4 59–82 0.04
Pre-dialysis creatinine mg/dL 8.162.73 4.9–10.30 7.792.49 4–9.70 0.62
Post-dialysis creatinine mg/dL 5.011.9 4.2–7.90 6.521.61 4.60–8 0.02
Cc1 mL/min 9.942.93 7.14–20.92 6.741.63 3.94–9.34 0.01
L/session/1.73 m2 9.791.13 6.94–11.34 7.401.21a 5.53–9.79 0.031
L/week/1.73 m2 68.54.43 49.60–73.36 58.852.57 43.73–68.49 0.035
Cur mL/min 19.851.95 15.67–23.01 10.632.62 8.38–12.52 0.001
Kt/V (session) 0.340.14 0.18–0.50 0.260.07a 0.12–0.39 0.001
Kt/V (week) 2.430.87 1.11–3.49 1.800.32 1.47–2.75 0.001
SRI Dialysate 28.464.6% 41–57.9% 20.645.93% 14–36.45% 0.02
SRI Kt/V 21.064.03% 15.62–30.48% 15.535.45% 9.5–21.47% 0.02
UF ml/min 4.280.70 3.01–5.8 1.820.13 0.80–2 0.04
L/session 2.880.71 1.89–4.14 2.010.28a 0.38–2.44 0.03
The difference was considered statistically significant by paired t test for P  0.05 for N  87. Cur is dialysate urea.
a Values of CEPD tabulated for 24 hours for comparison
Table 5. Comparison of total protein, albumin losses, dextrose absorption, potassium and phosphate clearances in TPD and CEPD
TPD CEPD
Variables Mean  SD Range Mean  SD Range P value
Total protein loss g/session 10.491.55 5.16–16.25 6.631.25 4.92–10.38 0.001
Albumin loss g/session 6.321.03 3.18–12.23 3.482.10 1.65–9.30 0.02
Potassium clearance mL/min 24.565.8 19–34.26 16.814.6 10.23–25 0.01
Phosphate clearance mL/min 14.235.4 8.21–30 9.603.90 5–15.23 0.042
Dextrose absorption g/session 98.6321.43 56–158.14 168.2723.80 118–282 0.0001
The difference considered statistically significant by paired t test for P  0.05 for N  87.
(P  0.09). Similarly, in the CEPD group Kt/V corre- of PD (CEPD and TPD), while 23 underwent two and
just four patients required three sets of dialysis. Onesponded to 0.90  0.04 and 0.87  0.03 with SRIdialysate,
SRIKt/V, respectively (P  0.08). Within the same treat- patient had sudden death in the polyuric phase of acute
ment group, SRIdialysate and SRIKt/V were not significantly tubular necrosis (ATN) due to pacemaker failure. Out
different (TPD and CEPD P values were 0.082 and 0.097, of 87 patients, four required implementation of HD when
respectively). PD was judged inadequate to control uremia (one pa-
Statistically significant higher losses of protein and tient with RPGN and 3 with superimposed septicemia
albumin and clearances of potassium and phosphorous following viperine snakebite). The adequacy parameters
were observed with TPD (Table 5). Ultrafiltrate was in these four patients were as follows: Normalized creati-
greater in TPD, while glucose absorption was more in nine clearance (L/session/1.73 m2 BSA) of 6.94  1.72
CEPD (Tables 4 and 5). The cost of TPD was less than in TPD, 5.53  0.18 in CEPD and Kt/V (per session)
CEPD (difference was Indian Rs. 688; Table 6). 0.18  0.05 in TPD, 0.12  0.02 in CEPD.
In the TPD group, 9 (7%), 9 (7%), 17 (15%), 83 (70%)
sessions were graded from 0 to 3, respectively, while in
DISCUSSIONthe CEPD group, 38 (32%), 39 (33%), 15 (13%), 26
This was a prospective randomized crossover study(22%) sessions were graded from 0 to 3, respectively.
involving 87 patients with mild-to-moderate hypercata-Hence, 70% of sessions in TPD and only 22% in CEPD
bolic ARF who were subjected to 236 treatment sessionswere graded with the highest level of satisfaction. None
of PD (CEPD  118, TPD  118). Patients with mild-to-of the patients experienced abdominal pain during rapid
moderate hypercatabolic ARF (excess UNA12 g/day)exchanges of TPD.
were included in the study. The washout period wasThree episodes of post-dialysis peritonitis due to S.
adequate in between the two sessions of dialysis. Thereaureus were observed after CEPD. Peritoneal leaks were
was a significant difference between pre- and post-dial-noted in five sessions (4 with CEPD, 1 with TPD) and
ysis BUN and creatinine for both the groups. Mean ureaone catheter required exchange due to partial blockage.
Sixty patients became dialysis free after a single set clearances (mL/min) for TPD was 19.85  1.95 and that
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Table 6. Cost comparison between the treatment protocols (CEPD for 48 hours and TPD for 12 hours)
Type of expenses Cost per day CEPD TPD
Labor and consumable items Rs. 375/day Rs. 750 Rs. 100
Labor charges (nursing, (US $ 8.30)a (US $ 16.60) (US $ 2.22)
paramedical, clerical, adminis- (I $ 34.28)b (I $ 68.56) (I $ 9.14)
trative and resident doctors, etc.).
Consumables
Dietary supplies
Nonconsumable items Rs. 75/day Rs. 150 Rs. 37.5
(maintenance, power, telecommunications, (US $ 1.66) (US $ 3.32) (US $ 0.83)
data process) (I $ 6.86) (I $ 13.71) (I $ 3.43)
Others Rs. 50/day Rs. 100 Rs. 25
(taxes, depreciation, interest rates, etc.) (US $ 1.11) (US $ 2.22) (US $ 0.55)
(I $ 4.57) (I $ 9.14) (I $ 2.29)
Cost of dialysis
Expense of machine Rs. 150/session 0 Rs. 150
(Total cost of machine  (US $ 3.33) (US $ 3.33)
Rs. 360,000, US $ 8000) (I $ 13.71) (I $ 13.71)
Expense of consumables
Baxter Bags Rs. 250/L Rs. 6500 Rs. 6500
(US $ 5.55) (US $ 144.45) (US $ 144.45)
(I $ 22.85) (I $ 594.15) (I $ 594.15)
Dialysis set Rs. 350 Rs. 350
(US $ 7.78) (US $ 7.78)
(I $ 31.99) (I $ 31.99)
Total Rs. 7850 (US $ 174.44) Rs. 7162.5 (US $ 159.14)
(I $ 717.55) (I $ 654.71)
a US dollars (approximately 1 US $  45 Indian Rupees)
b International dollars (Rupees 10.94 spent in India are equal to I $ 1)
for CEPD was 10.63  2.62, while the creatinine clear- washout periods of two to three days have been used
[30]. In hypercatabolic ARF with rapid accumulation ofances in TPD was 9.94  2.93 and in CEPD was 6.74 
1.63 (P  0.001). Similarly, in TPD and CEPD the nor- uremic toxins, a minimum washout period of 12 hours
was considered adequate. Tenckhoff catheters have pro-malized creatinine clearances (L/week/1.73 m2 BSA)
were 68.5 4.43 and 58.85 2.57, and estimated weekly ven to be superior to stiff stylet or Cook catheters [31],
however, the latter are still used for intermittent perito-Kt/V values were 2.43  0.87 and 1.80  0.32, respec-
tively. TPD achieved the standards of adequacy as per neal dialysis at most of the centers in India due to its
low cost and ease of introduction [4].the NKF guidelines, while CEPD fell short of the stan-
dards [18]. Kt/V appropriately measured the solute losses There are a number of factors contributing to net
protein breakdown in patients with ARF. These are inad-in PD. Tidal peritoneal dialysis was superior to CEPD in
the removal of potassium, phosphates and in generating equate supply of nutritional substrates, loss of nutritional
substrates during dialysis, increased circulating concen-ultrafiltrate. TPD was better tolerated, consumed less
time and was less expensive. Excess protein loss was the tration of catabolic hormones, systemic inflammatory
response syndrome and exposure to bio-incompatibleonly limitation of TPD in ARF.
In the present study, the young age of patients with membrane during hemodialysis. [32]. Inadequate protein
intake in Indian renal failure patients is common, whichARF, and the predominance of medical causes of ARF
(due to acute diarrheal illnesses, infections like malaria may compound negative nitrogen balance [33, 34]. The
methods of assessing catabolism and definitions of catab-and leptospirosis, hemolysis secondary to glucose 6-pho-
phate deficiency, insect and snake bites) are consistent olism vary from biochemical indices (rate of rise of BUN,
serum creatinine, uric acid, potassium, phosphorous) towith the experiences reported from other centers in India
[2]. In recent years, the pattern of acute renal failure in the net production of urea of more than 25 g/day [7–10,
20]. In renal insufficiency, UNA provides a better meth-India has shown a change similar to that noted in the
West, albeit at a less impressive pace [4]. od for the assessment of protein catabolism [21].
Katirtzoglou et al used CEPD for five hypercatabolicPatients with ARF represent a heterogeneous cohort
with a wide variety of causes and contributing factors patients and seven with non-hypercatabolic ARF or
acute exacerbation of CRF, and observed an adequateleading to renal shut down, presenting with varying se-
verity and at different stages. A crossover study design decrease in BUN and serum creatinine [8]. Cameron and
colleagues treated 15 patients with ARF due to burns,was utilized to eliminate confounding variables. In other
studies with a crossover design in stable CRF patients, cardiac and aortic surgery, with the rate of urea produc-
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tion of more than 0.88 g/kg/day with PD and 1 to 3 L/h the significance of SRI in PD. Kt/V in PD quantifies
directly the amount of solute removed in the effluentexchanges [10]. With urea dialysance of 13 to 20 mL/
min, all except for 2 of the 15 patients were able to for the amount of dialysis time and factored for urea
distribution. Hence, Kt/V in PD is a dialysate-basedmaintain a BUN value 200 mg/dL, which the authors
considered satisfactory control (13.4 g of peritoneal urea method rather than a blood-based method as in HD.
In contrast to HD, PD allows the steady equilibrationnitrogen clearance vs. 28.7 g of urea nitrogen produc-
tion). This led them to conclude that hypercatabolism between the blood and dialysate compartment and urea
redistribution, and the kinetics (single and double pool)alone is not a contraindication to PD use. Indraprasit
et al treated 10 patients with continuous dialysis using do not pose an issue in PD. A marginal difference ob-
tained between SRIdialysate and Kt/V supports the fact thatTenckhoff catheters with 1 to 1.5 L exchanges, and dwell
adjusted to maintain adequate waste products, fluid and the latter does not overestimate solute removal in PD.
Clearances of small molecules on peritoneal dialysiselectrolyte balance for 2 to 30 days [9]. They noted urea
clearance of 12.1  1.2 mL/min equivalent to 120 mL/ depend on the permeability of the peritoneal membrane,
volume of effluent drained and total time on dialysis.min of hemodialysis clearance over four hours. Each of
these studies and others suffer from limited sample size TPD is claimed to increase solute clearances by increas-
ing peritoneal membrane contact at the end of drainageand inappropriate or lack of measurements for catabolic
state [7–14]. Furthermore, success of PD was based on and the beginning of infusion and by preventing the
formation of a stagnant fluid film by maintaining highcontrol of fluid, electrolyte and solute balance, as these
studies were completed before the concept of “ade- dialysate flow rate. However, Flanigan et al observed
that the amount of dialysate necessary to achieve thesequacy” evolved.
Adequacy of dialysis dose in ARF is a subject of con- clearances exceeded that needed in CCPD (continuous
cyclic peritoneal dialysis) by 68% and CAPD by 150%troversy for many reasons [15–17]. Recent studies have
shown that dialysis dose is one of the major contributing [35, 36]. Increase in solute clearances in PD is found to
be in proportion to dialysate flow rate [30, 35–37]. Infactors to patient survival (abstract; Schiff et al, J Am Soc
Nephrol 8:290A, 1997). There is no satisfactory marker of the present study, TPD with high flow rate (37 mL/
min) yielded greater solute clearances and ultra filtratedialysis adequacy in ARF [17]. There are a number of
reasons preventing extrapolation of the clearance-based volume as compared to CEPD (9 mL/min), though the
total volume of fluid used was the same.dialysis dosage (Kt/V and normalized creatinine clear-
ance) from the chronic dialysis population to acute dial- In the present study, differences of 51% and 37% were
observed between BUN and creatinine in the TPD andysis [16, 17]. These include the hypercatabolic state in
ARF as compared to “eubolism” in ESRD patients. In CEPD groups, respectively. The higher differences ob-
served in TPD are due to the short dwell time, whichARF, water content of the body is increased due to
excessive production of endogenous water. Urea kinetic increases discrepancies between urea and creatinine ki-
netics [36]. Urea and creatinine clearances obtained inmodeling is not validated in ARF. Urea generation can
vary from hour to hour requiring a dynamic urea kinetic the present study were higher for the total dialysate fluid
and the flow rate as compared to other studies (Tablemodel. Finally, there is currently no consensus on what
levels of urea solute removal are adequate or optimal. 7) [9, 11, 30, 37–40]. Comparison among these studies
ideally cannot be done due to the differences in the studyIt has been suggested that in the absence of a consensus,
it seems reasonable to at least attempt to deliver dialysis populations (animal model in Ash et al vs. humans),
causes of renal failure (ARF vs. CRF) and treatmentdoses similar to those received by patients with CRF
[17]. Hence, we have compared doses of PD received protocols [9, 11, 30, 37–40]. Nevertheless, higher clear-
ances could be explained by the racial differences inby ARF patients with the present standard for CRF
patients on maintenance dialysis as per the NKF guide- peritoneal permeability characteristics, higher reserve
volume, utilization of a larger effective surface area oflines [18].
The solute reduction index (SRI) used in HD (a dialy- peritoneum and possibly by changes in the permeability
of peritoneal membrane in ARF [41–48]. It has beensate-based index) measures the total amount of urea
removed during a dialysis treatment, while the blood- shown that the peritoneal surface correlates well with
the body surface area [42]. The average BSA of Asiansbased method, namely, Kt/V, measures the fractional
change in blood urea concentration [16]. SRI is not in- is less than that of Africans and Caucasians and there-
fore, the Asians would have a proportionately lowerfluenced by urea redistribution or the type of kinetics
employed [19]. Therefore, in HD SRI is considered by peritoneal surface area (average BSA of Asian, Africans
and Americans is 1.65, 2.06, 1.89 m2, respectively) [44–many to be the gold standard for measuring the dose of
dialysis. Evanson et al noted Kt/V to overestimate the 46]. Hence, with the same volume of infused fluid a
proportionately larger effective peritoneal surface areadose of dialysis in HD in patients with ARF as compared
to a dialysate-based index [16]. There are scant data on would be utilized. Increased levels of circulating in-
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Table 7. Comparison of total dialysate, flow rate, solute, potassium, phosphate clearances, protein and albumin losses in various studies
TPD CEPD
Vychytil et al [38]
Steinhauer Pirano et al Ash et al Indraprasit Gateldi et al Ash et al Chitalia
Variables et al [40] [30] [39] Low flow High flow Chitalia et al et al [9] [11] [39] et al
Total fluid L 23 30 14.4 15 30 26.3 N/A 10 2 26
Flow rate mL/min 51 62.5 63 28 50 37 N/A 6.9 8.3 9
Reserve vol mL 0.75–1 1 1 1.25 0.75 1.325 0 0 0 0
Cur mL/min 19.53.2 203 22.1 13.191.74 17.252.36 19.851.95 12.11.2 7.621.28 10.4 10.632.62
Cc1 mL/min 15.21.7 103 8.91.48 11.31.89 9.942.93 5.41.02 6.741.63
UF mL/min 4.730.92 3.31.6 1.060.21 1.160.34 4.280.7 1.820.13
Phosphate clearance
mL/min 10.51.29 113 7.621.24 9.351.72 14.235.4 9.63.9
Potassium clearance
mL/min 18.53 244 24.562.58 16.814.6
Protein loss
g/session 17.482.72 5.130.51 4.540.49 10.491.55 6.631.25
Albumin loss
g/session 6.60.6 3.470.3 3.400.31 6.321.03 3.481.14
Dextrose absorption
g/session 57.33.78 69.7610.06 98.6321.43 16512.67 168.2723.8
a Observations in live normal dog. Urea clearance is derived from glucose clearance, urea clearance twice of glucose clearance) [9, 11, 30, 37-40].
flammatory mediators and cytokines have been observed ratory function [51]. The use of a lower volume of fluid
for a shorter period of time in TPD would minimize thisin ARF [47]. Local prostaglandins have been shown to
increase peritoneal membrane permeability [48]. It is problem.
A hospital bed in the developing world is cheaper thatplausible that the cytokines and prostaglandins in ARF
could alter the permeability of the peritoneal membrane. in the United States (average cost of a dialysis bed in
USA  US $500–1000, while in India would be US $11–Obligatory protein and albumin losses can compound
the negative nitrogen balance in ARF, especially if the 12), especially in a government run hospital. The Baxter
dialysate used for the study was imported, thereby in-dialysis is continued for a longer period of time. Most
of the patients in this study became dialysis free after creasing the cost of dialysate. The cost could be substan-
tially reduced if the fluid could be manufactured locally.four treatments of PD. Protein losses as high as 48 grams
per session [49] have been reported in intermittent peri- In CRF patients on home cycler dialysis, higher costs
due to the requirement for more dialysate to achievetoneal dialysis. Higher potassium and phosphorous clear-
ances were noted in the present study as compared to the same clearances seen in TPD is a major concern
[36]. However, for in-patient dialysis, the occupation ofthe CRF population (Table 7). Also, it has been shown
that in TPD potassium kinetics closely follow the creati- a dialysis bed for a shorter time and a reduced need for
the trained nursing staff decreased the cost of TPD. Thenine kinetics [36]. A wide difference between these two
kinetics was observed in the present study. This may be cost of a dialysis bed is greater for manually performed
CEPD, which requires trained nursing staff for longerexplained by the presence of hyperkalemia and hyper-
phosphatemia in hypercatabolic ARF. The greater po- time periods. The estimated cost presented here is for
a government run university hospital and would betassium and phosphorous clearances observed with TPD
compared to CEPD may be due to the higher flow rate higher in a private hospital.
Our study presents evidence of adequate solute re-(Table 5). Dextrose absorption of more than 500 g/day
has been observed in patients receiving PD with a 4.5% moval by PD for mild-to-moderate hypercatabolic ARF
in the developing countries according to the existingsolution [50], and this can lead to hepatic steatosis,
increased CO2 production and worsening respiratory fail- standards of adequacy. One of the limitations of this
study is that the patient base differs from the most ofure. On the other hand, dextrose absorption can contrib-
ute 500 to 2000 calories per day to substantially con- the studies dealing with the hypercatabolic ARF. The
patients in the present series predominantly were mild-tribute to caloric supplementation in the hypercatabolic
state and facilitate cellular uptake of potassium to con- to-moderate hypercatabolic rather than the severe
hypercatabolic patients (rhabdomyolysis, multi-organtrol hyperkalemia [50]. The higher dextrose absorption
observed in CEPD is due to a longer dwell time, allowing failure, and sepsis syndrome) found in other series.
Therefore, these findings may not apply to the patientprolonged contact of dialysate for dextrose absorption.
Obviously, TPD being shorter was perceived as more population in the developed countries due to differences
in etiologies, co-morbid conditions and level of hyperca-comfortable than CEPD. Disturbances of blood gas ex-
change from abdominal dialysate distension may cause tabolism. Many of the infectious conditions leading to
ARF in developing countries are self-limiting and renalserious sequela in ARF patients with compromised respi-
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